Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Terminated(1)

Detailed Status

Withdrawn1
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

withdrawn133%
active_not_recruiting133%
not_yet_recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruitingnot_applicable

MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or HER2+ MBC

NCT03881605
not_yet_recruitingnot_applicable

MAgnetic Resonance Imaging-guided implanTation of Cardioverter DEFibrillators

NCT06269692
withdrawnnot_applicable

Initial Evaluation of Ultra FAST Breast Magnetic Resonance in Breast Cancer Screening: Comparative Study With Mammography and Ultrasound.

NCT02324894

Clinical Trials (3)

Showing 3 of 3 trials
NCT03881605Not Applicable

MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or HER2+ MBC

Active Not Recruiting
NCT06269692Not Applicable

MAgnetic Resonance Imaging-guided implanTation of Cardioverter DEFibrillators

Not Yet Recruiting
NCT02324894Not Applicable

Initial Evaluation of Ultra FAST Breast Magnetic Resonance in Breast Cancer Screening: Comparative Study With Mammography and Ultrasound.

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3